Quantitative SARS-CoV-2 anti-spike responses to Pfizer-BioNTech and Oxford-AstraZeneca vaccines by previous infection status (2021)

First Author: Eyre D

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2021.03.21.21254061

Publication URI: http://dx.doi.org/10.1101/2021.03.21.21254061

Type: Preprint